EUVIMEDEUVIMED entdecken
Kohortenstudie

Long-Term Thyroid Outcomes After COVID-19 Vaccination: A Cohort Study of 2 333 496 Patients From the TriNetX Network

Kai-Lun Cheng iD, Wei-Shin Yu, Yu-Hsun Wang, Gema Hernández Ibarburu iD, Hsiang-Lin Lee iD, James Cheng-Chung Wei iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf064 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Kai-Lun Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Hypothyroidism, Hyperthyroidism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Chung Shan Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Reports on long-term thyroid dysfunction following COVID-19 vaccination are limited. Understanding the risk of subacute thyroiditis, hyperthyroidism, and hypothyroidism in vaccinated individuals is crucial for postvaccination monitoring.

Objective

This study evaluated the risk of thyroid dysfunction in individuals vaccinated against COVID-19 compared to unvaccinated individuals, using a large cohort.

Methods

We conducted a retrospective cohort study from January 1, 2022, to December 31, 2023, using the TriNetX database, including 1 166 748 vaccinated and 1 166 748 unvaccinated individuals. Propensity score matching was used to balance baseline characteristics. The primary outcomes were new diagnoses of subacute thyroiditis, hyperthyroidism, and hypothyroidism.

Results

The risk of subacute thyroiditis remained unchanged (95% CIs included 1). A significant reduction in hyperthyroidism risk was observed from 3 to 9 months postvaccination (hazard ratios [HRs]: 0.65-0.89, all 95% CIs below 1), but this trend was not significant at 12 months (HR: 0.99; 95% CI: 0.92-1.06). In contrast, the risk of hypothyroidism significantly increased from 6 to 12 months postvaccination (HR: 1.14-1.30, all 95% CIs above 1). Among mRNA vaccine recipients, the risk of both hyperthyroidism and hypothyroidism was significantly elevated at 12 months (HR: 1.16-2.13).

Conclusion

COVID-19 vaccination was associated with a reduced risk of hyperthyroidism and an increased risk of hypothyroidism, highlighting the need for ongoing thyroid function monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19HypothyroidismHyperthyroidismVaccinationThyroiditis, SubacuteThyroid DiseasesHumansMaleFemaleMiddle AgedRetrospective StudiesAdultAgedSARS-CoV-2Cohort Studies

Stichwörter der Autor:innen

COVID-19 vaccinationhyperthyroidismhypothyroidismretrospective cohort studysubacute thyroiditisthyroid dysfunction

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
  • Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
  • Department of Internal Medicine, Division of Endocrinology and Metabolism, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
  • Department of Medical Research, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
  • Academic Research and Education Support Lead, TriNetX, Cambridge, MA 02140, USA.
  • Department of Surgery, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.

ORCID-Profile: Kai-Lun Cheng, Gema Hernández Ibarburu, Hsiang-Lin Lee, James Cheng-Chung Wei

Förderung

  • Chung Shan Medical University Hospital

Zitieren

APA

Cheng, K. L., Yu, W. S., Wang, Y. H., Ibarburu, G. H., Lee, H. L., & Wei, J. C. (2025). Long-Term Thyroid Outcomes After COVID-19 Vaccination: A Cohort Study of 2 333 496 Patients From the TriNetX Network. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf064

Vancouver

Cheng KL, Yu WS, Wang YH, Ibarburu GH, Lee HL, Wei JC. Long-Term Thyroid Outcomes After COVID-19 Vaccination: A Cohort Study of 2 333 496 Patients From the TriNetX Network. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf064

BibTeX
@article{Cheng2025,
  author = {Cheng, Kai-Lun and Yu, Wei-Shin and Wang, Yu-Hsun and Ibarburu, Gema Hernández and Lee, Hsiang-Lin and Wei, James Cheng-Chung},
  title = {Long-Term Thyroid Outcomes After COVID-19 Vaccination: A Cohort Study of 2 333 496 Patients From the TriNetX Network},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf064}
}
Kostenlos starten →